Share this:
Heart disease remains a leading cause of death around the world. And diabetes is one of the risk factors for heart disease. Diabetes is a growing global health concern, with more than 422 million people living with this metabolic disorder — the majority of those with Type 2 diabetes.
Dr. Gosia Wamil, a cardiologist at Mayo Clinic Healthcare in London, has long been researching the link between diabetes and heart disease. She says, for people with diabetes, there are new treatment strategies.
Journalists: Broadcast-quality video (0:58) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic News Network." Read the script.
Through her research on diabetes and heart disease, Dr. Wamil says she learned a lot about "the role of chronic inflammation and insulin resistance as a mechanism that starts the process of atherosclerosis."
And atherosclerosis can lead to coronary artery disease and heart attack.
That's where diet and exercise can help.
"We have evidence and scientific data that support that weight reduction, improvement in blood pressure are very important strategies to reduce the risk of diabetes and, therefore, complications of diabetes and heart diseases," says Dr. Wamil.
New treatments and therapies are also available.
"We have, for the first time, developed glucose-lowering treatments that at the same time address the problem, the link between their diabetes and heart diseases," Dr. Wamil says.
Related posts:
- Mayo Clinic Healthcare expert shares heart failure signs, risk factors people may not be aware of.
- Mayo Clinic Q&A podcast: Reducing the risk of heart failure.
- Mayo Clinic Healthcare in London expands advanced cardiac imaging services.
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.
Share this:
Related articles
ROCHESTER, Minn. — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of ...
ROCHESTER, Minn. — Heart failure is a potentially urgent health concern for young adults with congenital heart disease (ACHD) that is often overlooked and undertreated, ...
Mayo Clinic doctors are using innovation to improve the lives of people who suffer from congestive heart failure and other chronic heart conditions. The Organ ...